Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2844
Source ID: NCT01469468
Associated Drug: Simvastatin
Title: A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: Simvastatin|DRUG: PF-05175157
Outcome Measures: Primary: Area under the plasma concentration curve of simvastatin and simvastatin acid, 10 days|Maximum observed plasma concentration of simvastatin and simvastatin acid, 10 days|Time at which maximum plasma concentration of simvastatin and simvastatin acid is observed, 10 days|If the data permit, area under the plasma concentration curve of simvastatin and simvastatin acid extrapolated to infinite time, 10 days|If the data permit, terminal elimination half-life of simvastatin and simvastatin acid, 10 days |
Sponsor/Collaborators: Sponsor: Pfizer
Gender: ALL
Age: ADULT
Phases: PHASE1
Enrollment: 14
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Start Date: 2011-11
Completion Date: 2011-12
Results First Posted:
Last Update Posted: 2018-11-14
Locations: Pfizer Investigational Site, South Miami, Florida, 33143, United States
URL: https://clinicaltrials.gov/show/NCT01469468